FDA Approves Device for Low Back Pain

July 02, 2020

By Rheumatology Network Editorial Staff

Doctor Visits, Complex Cases and Good Outcomes

July 01, 2020

By Rheumatology Network Editorial Staff

RA Quiz: Measures of Mortality

July 01, 2020

By Ingrid Torjesen

Vaccinate in Pediatric Rheumatology, but Pass on COVID-19 Antibody Test

June 30, 2020

By Rheumatology Network Editorial Staff

Goldilocks: Promoting Collaborative Decision-Making

June 30, 2020

By Kim A. Gorgens, Ph.D., ABPP

Rheumatology News Roundup: Mobile Apps in Healthcare Research

June 26, 2020

In today's news roundup, we feature a discussion with Ben Nowell, Ph.D., director of Patient Centered Research for the Global Healthy Living Foundation, which five years ago launched ArthritisPower, a mobile app used in healthcare research. Learn more in this interview.

4 Recommendations for Treating Fatigue in RA

June 25, 2020

There are many treatments and strategies to address fatigue in rheumatoid arthritis (RA) patients, but no one approach works for all patients. In this slideshow, we highlight key takeaways from a recent review that highlights key strategies for treating fatigue in RA.

Vitamin D and Fish Oil Fail Osteoarthritis Trial

June 25, 2020

New research published in Arthritis and Rheumatology shows that vitamin D and marine omega‐3 fatty acids (n‐3 FA) do not offer long-term relief from knee pain, stiffness or function in older adults with chronic knee pain.

SpA Cases Flare Under COVID-19 Due to Misinformation

June 23, 2020

French researchers writing in Arthritis and Rheumatology report that of 609 surveyed spondyloarthritis patients self-isolating at home due to COVID-19, most say their condition has progressed while in isolation and for some, the change has been considerable.

Blood Thinner Could Prevent Osteoarthritis

June 23, 2020

Researchers writing in the current issue of Arthritis and Rheumatology report that a blood thinner may have potential as a preventive treatment for osteoarthritis.

Rheumatology News Roundup: Is it axSpA or fibromyalgia?

June 19, 2020

In this week's news roundup from Rheumatology Network, we feature a series of studies that focus on new treatments for rheumatic disease. We also highlight the newly approved secukinumab (Cosentyx, Novartis) for active non-radiographic axial spondyloarthritis (axSpA). Today, we feature a discussion with Dr. Alexis Ogdie-Beatty and Kelly Gavigan, the lead researcher on a recent study about the overlap between axSpA and fibromyalgia.

Osteoporosis Treatment Under COVID-19

June 19, 2020

A steering committee of the American Society for Bone Mineral Research recently issued COVID-19 treatment guidelines for patients receiving osteoporosis treatments. In this interview, E. Michael Lewiecki, M.D., director of the New Mexico Clinical Research and Osteoporosis Center and a University of New Mexico program called Bone Health TeleECHO, shares his best practices for treating osteoporosis patients during the pandemic.

Secukinumab Approved for Active Non-radiographic Axial Spondyloarthritis

June 19, 2020

Secukinumab, an IL-17a inhibitor currently approved in the United States for moderate to severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis, has been approved by the U.S. Food and Drug Administration for the treatment of active non-radiographic axial spondyloarthritis.

Status Report: The Rheumatoid Arthritis Drug Pipeline

June 18, 2020

The rheumatoid arthritis drug pipeline is robust with 243 molecules under study, but more than half end up dropping off through natural attrition.

EULAR Report: Physicians Increasingly Pass on Biosimilars

June 16, 2020

Rheumatologists still lack confidence in prescribing biosimilars, shows study presented at EULAR.

x